Christopher Fuglesang, 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 566,222 shares at $5.60 ($3.2M) on 2017-01-06, disclosed to the SEC on 2017-01-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.60 | 6,104 | $34K | 1.1% |
| 2 | $5.60 | 280,059 | $1.6M | 49.5% |
| 3 | $5.60 | 280,059 | $1.6M | 49.5% |
| Total | $5.60 avg | 566,222 | $3.2M | 100% |
| Filing → |